CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 10, 2022 · earnings

GLUE earnings: a positive outcome, +5.3%

On November 10, 2022, Monte Rosa Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.3% in the window around the event. It had already run +16.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$7.60
1d before
$8.00
Event day
$9.07
1d after
$9.42
5d after

Pre-catalyst setup

+16.2%
30-day run-up
8071%
30-day volatility
5.4×
volume spike